The clinical validation of gold-195m: a new short half-life radiopharmaceutical for rapid, sequential, first pass angiocardiography in patients

J Am Coll Cardiol. 1983 Jul;2(1):85-92. doi: 10.1016/s0735-1097(83)80380-5.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Angiocardiography / adverse effects
  • Angiocardiography / methods
  • Cardiomyopathies / diagnostic imaging
  • Clinical Trials as Topic
  • Cyanides / blood
  • Gold*
  • Half-Life
  • Heart Ventricles / diagnostic imaging
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Myocardial Infarction / diagnostic imaging*
  • Radioisotopes*
  • Radionuclide Imaging
  • Stroke Volume
  • Technetium
  • Thiocyanates / blood
  • Time Factors

Substances

  • Cyanides
  • Radioisotopes
  • Thiocyanates
  • Technetium
  • Gold